Skip to main content

Enhancing Cardiac Surgeries with Hemostatic Patches

 

Cardiac surgery has witnessed remarkable advancements in recent years, and one such breakthrough is the use of hemostatic patches. These innovative patches play a crucial role in managing bleeding during and after cardiac procedures, promoting better patient outcomes. Aegis Lifesciences, a leading medical device company, offers an exceptional solution in the form of Surgispon® Patch, revolutionizing the field of cardiac surgery.

Benefits of Hemostatic Patches in Cardiac Surgery:

  1. Superior Hemostasis: Surgispon® Patch effectively controls bleeding by forming a stable clot within seconds of application. This reduces the risk of excessive bleeding and minimizes the need for blood transfusions during cardiac procedures.
  2. Ease of Use: The Surgispon® Patch is user-friendly and easy to handle, allowing surgeons to apply it precisely and quickly. Its conformable and flexible nature enables seamless integration into various surgical sites, ensuring optimal hemostasis.
  3. Enhanced Patient Safety: By reducing bleeding complications, hemostatic patches contribute to improved patient safety. Surgispon® Patch minimizes the risk of postoperative complications, such as hematoma formation, which can lead to infection or impaired wound healing.
  4. Cost-Effective Solution: Hemostatic patches reduce procedure time and the need for additional hemostatic agents, resulting in potential cost savings. The decreased reliance on blood transfusions can also lead to lower healthcare expenses.

Aegis Lifesciences offers Surgispon® Patch as a reliable solution for cardiac surgeons. Manufactured using high-quality materials, the patch demonstrates excellent biocompatibility and absorption properties. With its exceptional performance, Surgispon® Patch has gained recognition and is widely used in cardiac surgeries worldwide.

Conclusion: Hemostatic patches, such as Surgispon® Patch from Aegis Lifesciences, have significantly transformed cardiac surgery by improving hemostasis and patient outcomes. These patches offer superior bleeding control, ease of use, enhanced patient safety, and cost-effectiveness. With Aegis Lifesciences’ commitment to innovation and quality, surgeons can rely on Surgispon® Patch to optimize surgical outcomes and improve the overall patient experience in cardiac surgery.

To learn more about Surgispon® Patch and Aegis Lifesciences’ range of medical solutions, Click Here

Comments

Post a Comment

Popular posts from this blog

Comprehensive Health Check-Up: A Commitment to Employee Well-Being

Image
Introduction In today’s fast-paced work environment, the health of employees can often take a back seat to the pressures of meeting deadlines and maintaining productivity. However, maintaining a healthy workforce is crucial for fostering a positive work environment and ensuring long-term organizational success. Regular health check-ups at the office serve as an effective means to address this challenge, ensuring that employees have access to necessary health assessments without the need to disrupt their work routines. The positive impact of these initiatives not only improves employee well-being but also reinforces the company’s commitment to a healthier workforce. This blog will delve into why these check-ups are crucial and provide insights into how they can be effectively implemented in the workplace. Aegis Lifesciences Leads the Way in Workplace Wellness It’s often said that prevention is better than cure, a principle that Aegis Lifesciences upholds in its commitment to employee he
Read more

Role of Surgi-ORC® Fibril and SURGISPON® in Posterior Fossa Tumor Resections

Image
  In posterior fossa tumor resections, Surgi-ORC® Fibril and SURGISPON® play crucial roles in facilitating a successful surgery and promoting optimal patient outcomes. Here's how they contribute to the surgical process: Hemostasis : One of the primary roles of both Surgi-ORC® Fibril and SURGISPON® is to assist in achieving hemostasis, which is the control of bleeding during surgery. Posterior fossa tumor resections can involve intricate procedures near sensitive structures such as the brainstem and cranial nerves, where bleeding must be carefully managed to maintain a clear surgical field and prevent complications. Surgi-ORC® Fibril and SURGISPON® are applied to bleeding surfaces to promote clot formation and minimize bleeding, thus enhancing visibility and surgical precision. Tissue Protection : During posterior fossa tumor resections, it's essential to protect delicate neural tissues from damage during surgical manipulation. Surgi-ORC® Fibril and SURGISPON® act as physical ba
Read more

Revolutionizing Total Knee Arthroplasty: The Role of ORC in Bleeding Control

  Effective   bleeding control   remains a formidable challenge in   modern surgery , particularly in orthopedic procedures where managing bleeding from the exposed or cut surface of cancellous bone is a critical concern.   Total knee arthroplasty   (TKA), a prevalent surgery for severe knee arthritis within orthopedics, is notably associated with significant blood loss due to extensive bone cutting and exposure of a large surface area of cancellous bone [1]. Challenges in TKA: Patients undergoing primary TKA are particularly susceptible to significant intraoperative and postoperative blood loss, leading to potential complications such as pain, decreased range of motion, and delayed recovery. With an aging population and increased life expectancy, the annual incidence of TKA procedures is expected to rise, reaching an estimated 3 million in the United States by 2030 [2]. Role of Absorbable Haemostatic Agents: To address bleeding challenges in orthopedic surgeries, particularly in TKA,
Read more